StockIQpro
NASDAQ:GNPX

Genprex, Inc.

Genprex, Inc. reported net income of −$16.2M in fiscal 2025.Summary generated from Genprex, Inc.'s SEC filings. Latest annual report filed Mar 30, 2026.

Revenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−338.7%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count changen/a

Financials

Fiscal years, $M
Item20212022202320242025
Revenue0000n/a
Operating income−21−24−31−21−16
Net income−21−24−31−21−16
Free cash flow−14−18n/an/an/a

Recent filings

From SEC EDGAR

Peers

Pharmaceutical preparations